These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 28103644)
1. Flow cytometric osmotic fragility test: Increased assay sensitivity for clinical application in pediatric hematology. Ciepiela O; Adamowicz-Salach A; Zgodzińska A; Łazowska M; Kotuła I Cytometry B Clin Cytom; 2018 Jan; 94(1):189-195. PubMed ID: 28103644 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Flow-Cytometric Osmotic Fragility Test for Hereditary Spherocytosis in Chinese Patients. Tao YF; Deng ZF; Liao L; Qiu YL; Deng XL; Chen WQ; Lin FQ Acta Haematol; 2016; 135(2):88-93. PubMed ID: 26505491 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis. Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337 [TBL] [Abstract][Full Text] [Related]
4. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis. Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414 [TBL] [Abstract][Full Text] [Related]
5. Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients. Tao YF; Deng ZF; Liao L; Qiu YL; Chen WQ; Lin FQ Ann Hematol; 2015 May; 94(5):747-51. PubMed ID: 25501660 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of patients with hereditary spherocytosis - an Indian scenario. Manivannan P; Tyagi S; Chandra D; Mishra P; Pati HP; Saxena R Hematology; 2018 Apr; 23(3):175-180. PubMed ID: 28914173 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric detection of erythrocyte osmotic fragility. Won DI; Suh JS Cytometry B Clin Cytom; 2009 Mar; 76(2):135-41. PubMed ID: 18727072 [TBL] [Abstract][Full Text] [Related]
8. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye. Mohapatra R; Warang P; Ghosh K; Colah R Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688 [TBL] [Abstract][Full Text] [Related]
9. Flow Cytometric Analysis of Erythrocytes Osmotic Fragility in Hereditary Spherocytosis: A Case-Controlled Study Evaluating the Best Anticoagulant, Sample Pre-Treatment and NaCl Concentration for Reliable Screening of this Red Blood Cell Membrane Disorder. Nobre CS; Silva JA; Jácomo RH; Nery LFA; Barra GB Cytometry B Clin Cytom; 2018 Nov; 94(6):910-917. PubMed ID: 30328264 [TBL] [Abstract][Full Text] [Related]
10. Percentage of hyperdense cells: Automated parameter to hereditary spherocytosis screening. Farias MG; Freitas PA Clin Biochem; 2015 Dec; 48(18):1341-3. PubMed ID: 26210847 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric osmotic fragility testing does reflect the clinical severity of hereditary spherocytosis. Shim YJ; Won DI Cytometry B Clin Cytom; 2014 Nov; 86(6):436-43. PubMed ID: 24243866 [TBL] [Abstract][Full Text] [Related]
12. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina. Crisp RL; Solari L; Vota D; García E; Miguez G; Chamorro ME; Schvartzman GA; Alfonso G; Gammella D; Caldarola S; Riccheri C; Vittori D; Venegas B; Nesse A; Donato H Ann Hematol; 2011 Jun; 90(6):625-34. PubMed ID: 21080168 [TBL] [Abstract][Full Text] [Related]
13. Modified osmotic fragility test for the laboratory diagnosis of hereditary spherocytosis. Judkiewicz L; Bartosz G; Oplatowska A; Szczepanek A Am J Hematol; 1989 Jun; 31(2):136-7. PubMed ID: 2660544 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric osmotic fragility--an effective screening approach for red cell membranopathies. Warang P; Gupta M; Kedar P; Ghosh K; Colah R Cytometry B Clin Cytom; 2011 May; 80(3):186-90. PubMed ID: 21298775 [TBL] [Abstract][Full Text] [Related]
15. Use of capillary blood to diagnose hereditary spherocytosis. Crisp RL; Solari L; Gammella D; Schvartzman GA; Rapetti MC; Donato H Pediatr Blood Cancer; 2012 Dec; 59(7):1299-301. PubMed ID: 22488885 [TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis. Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613 [TBL] [Abstract][Full Text] [Related]
17. Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis. Shahal-Zimra Y; Nosgorodcky Y; Eshel E; Rotem Z; Ross L; Pickholtz I; Rabizadeh E; Chezar J Cytometry B Clin Cytom; 2022 Sep; 102(5):377-383. PubMed ID: 34528390 [TBL] [Abstract][Full Text] [Related]
18. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders. Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141 [TBL] [Abstract][Full Text] [Related]
19. [Establishment of Method for Detecting Red Blood Cell Osmotic Fragility by Flow Cytometry]. Zhu HY; Meng Q; Ouyan HM; Dong T; Zhang QY; Zhou YQ; Ping ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):229-32. PubMed ID: 26913426 [TBL] [Abstract][Full Text] [Related]